Global Medical Reit Stock Net Asset
| GMRE Stock | USD 8.33 0.21 2.59% |
Global Medical REIT fundamentals help investors to digest information that contributes to Global Medical's financial success or failures. It also enables traders to predict the movement of Global Stock. The fundamental analysis module provides a way to measure Global Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Global Medical stock.
Global | Net Asset |
Global Medical REIT Company Net Asset Analysis
Global Medical's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Global Medical Net Asset | 1.27 B |
Most of Global Medical's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Global Medical REIT is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Global Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Global Medical is extremely important. It helps to project a fair market value of Global Stock properly, considering its historical fundamentals such as Net Asset. Since Global Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Global Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Global Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Global Total Assets
Total Assets |
|
Based on the recorded statements, Global Medical REIT has a Net Asset of 1.27 B. This is much higher than that of the Diversified REITs sector and significantly higher than that of the Real Estate industry. The net asset for all United States stocks is notably lower than that of the firm.
Global Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Global Medical's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Global Medical could also be used in its relative valuation, which is a method of valuing Global Medical by comparing valuation metrics of similar companies.Global Medical is currently under evaluation in net asset category among related companies.
Global Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Global Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Global Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Global Medical's value.| Shares | Stifel Financial Corp | 2023-12-31 | 840.4 K | Charles Schwab Investment Management Inc | 2023-12-31 | 793.2 K | Phocas Financial Corp | 2023-12-31 | 789.5 K | Bank Of New York Mellon Corp | 2023-12-31 | 693.2 K | Pacific Ridge Capital Partners, Llc | 2023-12-31 | 666 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 611.8 K | Northern Trust Corp | 2023-12-31 | 580.5 K | Lsv Asset Management | 2023-12-31 | 485.2 K | Goldman Sachs Group Inc | 2023-12-31 | 423.6 K | Vanguard Group Inc | 2023-12-31 | 6.1 M | Blackrock Inc | 2023-12-31 | 5.2 M |
Global Fundamentals
| Return On Equity | 0.0346 | ||||
| Return On Asset | 0.0178 | ||||
| Profit Margin | 0.15 % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | 1.22 B | ||||
| Shares Outstanding | 65.59 M | ||||
| Shares Owned By Insiders | 5.75 % | ||||
| Shares Owned By Institutions | 58.75 % | ||||
| Number Of Shares Shorted | 1.32 M | ||||
| Price To Earning | 39.78 X | ||||
| Price To Book | 1.07 X | ||||
| Price To Sales | 4.16 X | ||||
| Revenue | 156.65 M | ||||
| Gross Profit | 136.93 M | ||||
| EBITDA | 111.67 M | ||||
| Net Income | 20.61 M | ||||
| Cash And Equivalents | 22.46 M | ||||
| Cash Per Share | 0.34 X | ||||
| Total Debt | 624.19 M | ||||
| Debt To Equity | 1.02 % | ||||
| Current Ratio | 2.59 X | ||||
| Book Value Per Share | 7.76 X | ||||
| Cash Flow From Operations | 68.44 M | ||||
| Short Ratio | 2.89 X | ||||
| Earnings Per Share | 0.23 X | ||||
| Price To Earnings To Growth | (26.28) X | ||||
| Target Price | 10.79 | ||||
| Number Of Employees | 26 | ||||
| Beta | 1.15 | ||||
| Market Capitalization | 587.99 M | ||||
| Total Asset | 1.27 B | ||||
| Retained Earnings | (238.98 M) | ||||
| Working Capital | (604.99 M) | ||||
| Current Asset | 83.48 M | ||||
| Current Liabilities | 46.08 M | ||||
| Annual Yield | 0.10 % | ||||
| Five Year Return | 7.22 % | ||||
| Net Asset | 1.27 B | ||||
| Last Dividend Paid | 0.21 |
About Global Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Global Medical REIT's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Global Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Global Medical REIT based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Global Medical Piotroski F Score and Global Medical Altman Z Score analysis. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Global Stock analysis
When running Global Medical's price analysis, check to measure Global Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Medical is operating at the current time. Most of Global Medical's value examination focuses on studying past and present price action to predict the probability of Global Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Medical's price. Additionally, you may evaluate how the addition of Global Medical to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Global Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Global Medical. If investors know Global will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Global Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.61) | Dividend Share 0.21 | Earnings Share 0.23 | Revenue Per Share 2.152 | Quarterly Revenue Growth (0.09) |
The market value of Global Medical REIT is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global Medical's value that differs from its market value or its book value, called intrinsic value, which is Global Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global Medical's market value can be influenced by many factors that don't directly affect Global Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Global Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Global Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.